(August 11, 2023, 4:16 PM EDT) -- NEW YORK — The New York federal judge overseeing the acetaminophen autism spectrum disorder-attention deficit hyperactivity disorder (ASD-ADHD) multidistrict litigation has denied a motion by Johnson & Johnson Consumer Inc. (JJCI) for certification of an interlocutory appeal of her orders denying two motions to dismiss on the grounds of preemption and lack of causation....